Form D · Biotechnology
iReprogram, Inc
Ann Arbor, MI · CIK 0002147328
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $25M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $375K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-594101
Assumes 1.5% of $25,000,000 per PPM.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| RKCA, Inc. | 17655 |
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pradeep Seneviratne | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1600 Huron Pkwy Bldg 520
Ann Arbor, MI, 48109
Phone: 734-945-7163
Ann Arbor, MI, 48109
Phone: 734-945-7163